Abstract
Nonadherence is a significant medical problem in the United States, leading to excessive morbidity, mortality, and medical costs. In the conclusion to this two-part article, the authors describe a pilot study involving 311 patients taking an angiotensin-converting enzyme inhibitor that evaluates the principal factors for nonadherence to pharmaceutical therapy in patients with congestive heart failure.
MeSH terms
-
Academic Medical Centers
-
Adult
-
Aged
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
-
Comorbidity
-
Drug Therapy / psychology*
-
Enalapril / administration & dosage*
-
Female
-
Heart Failure / drug therapy*
-
Humans
-
Male
-
Middle Aged
-
Outpatient Clinics, Hospital
-
Patient Compliance*
-
Process Assessment, Health Care
-
Random Allocation
-
Risk Assessment*
-
United States
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Enalapril